Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Berek

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
JMIR Research Protocols|May 7, 2021
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot StudyPatrick Altmann, Werner Hinterberger, Fritz Leutmezer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 1, 2019
Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosisGabriel Bsteh, Klaus Berek, Harald Hegen, et al.
European Journal of Neurology|April 5, 2025
Reactive Pleocytosis After Repeated Lumbar Puncture-Implications for Clinical PracticeMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
Clinical Chemistry and Laboratory Medicine|April 19, 2025
Impact of renal function impairment on kappa free light chain indexMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 29, 2021
Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease ActivityKlaus Berek, Gabriel Bsteh, Michael Auer, et al.
European Journal of Neurology|May 10, 2023
Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhageAnna Lindner, Klaus Berek, Verena Rass, et al.
Journal of Neurology|April 9, 2026
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database studyHarald Hegen, Fabian Föttinger, Janette Walde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2022
Olfactory threshold predicts treatment response in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Klaus Berek, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2022
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysisHarald Hegen, Janette Walde, Klaus Berek, et al.
Frontiers in Neurology|August 12, 2025
High erythropoietin levels are associated with low neurofilament light levels in simulated high altitude: a further hint for neuroprotection by erythropoietinKlaus Berek, Anna Berek, Angelika Bauer, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
JMIR Research Protocols|May 7, 2021
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot StudyPatrick Altmann, Werner Hinterberger, Fritz Leutmezer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 1, 2019
Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosisGabriel Bsteh, Klaus Berek, Harald Hegen, et al.
European Journal of Neurology|April 5, 2025
Reactive Pleocytosis After Repeated Lumbar Puncture-Implications for Clinical PracticeMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
Clinical Chemistry and Laboratory Medicine|April 19, 2025
Impact of renal function impairment on kappa free light chain indexMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 29, 2021
Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease ActivityKlaus Berek, Gabriel Bsteh, Michael Auer, et al.
European Journal of Neurology|May 10, 2023
Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhageAnna Lindner, Klaus Berek, Verena Rass, et al.
Journal of Neurology|April 9, 2026
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database studyHarald Hegen, Fabian Föttinger, Janette Walde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2022
Olfactory threshold predicts treatment response in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Klaus Berek, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2022
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysisHarald Hegen, Janette Walde, Klaus Berek, et al.
Frontiers in Neurology|August 12, 2025
High erythropoietin levels are associated with low neurofilament light levels in simulated high altitude: a further hint for neuroprotection by erythropoietinKlaus Berek, Anna Berek, Angelika Bauer, et al.
Pageof 10